Cite
HARVARD Citation
Burris, H. et al. (2013). Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial12. Cancer. 119 (10), pp. 1908-1915. [Online].